JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 7 1383-1389
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doudet, D. J.
Right arrow Articles by Cohen, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doudet, D. J.
Right arrow Articles by Cohen, R. M.

Delayed L-Phenylalanine Infusion Allows for Simultaneous Kinetic Analysis and Improved Evaluation of Specific-to-Nonspecific fluorine-18-DOPA Uptake in Brain

Doris J. Doudet, Catherine A. McLellan, Thomas G. Aigner, Richard J. Wyatt and Robert M. Cohen

Section on Clinical Brain Imaging, LCM, NIMH, IRP
Laboratory of Neuropsychology, NIMH, IRP
Neuropsychiatry Branch, NJMH, IRP, Bethesda, Maryland

Correspondence: For reprints contact: Doris J. Doudet, Section on Clinical Brain Imaging, Bldg 10/4N317, LCM, NIMH, IRP. 9000 Rockville Pike, Bethesda, MD, 20892.

ABSTRACT

The accumulation of 3-O-methyl-6-[18F]fluoro-L-DOPA (18F-30M-DOPA) in the brain from the circulation is responsible for most of the nonspecific background during 18F-DOPA positron emission tomography scanning. To increase the sensitivity of 18F-DOPA for imaging presynaptic dopamine systems, we took advantage of 18F-30M-DOPA's rapid clearance from the brain (T1/2 ~ 15—20 min). The infusion of the unlabeled amino acid L-phenylalanine, starting 75 min after 18F-DOPA administration, prevents 18F-30M-DOPA entrance into the brain through competition at the large amino acid transport system of the blood brain barrier. This method produces high specific-to-nonspecific contrast images of 18F accumulation beginning 15–30 min after onset of amino acid infusion and better sensitivity to small changes in 18F-DOPA uptake while still allowing for kinetic analysis of the data in the early time points. Kinetic and anatomical data were found to be strongly correlated.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Ernst, A. J. Zametkin, J. A. Matochik, P. H. Jons, and R. M. Cohen
DOPA Decarboxylase Activity in Attention Deficit Hyperactivity Disorder Adults. A [Fluorine-18]Fluorodopa Positron Emission Tomographic Study
J. Neurosci., August 1, 1998; 18(15): 5901 - 5907.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Ernst, A. J. Zametkin, J. A. Matochik, D. Pascualvaca, P. H. Jons, K. Hardy, J. G. Hankerson, D. J. Doudet, and R. M. Cohen
Presynaptic Dopaminergic Deficits in Lesch-Nyhan Disease
N. Engl. J. Med., June 13, 1996; 334(24): 1568 - 1572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.